Ad
related to: what is navd elevation myocardial infarction treatmentLower LDL-C and Reduce the Risk of Another MI. Get Info on a Treatment Option That Lowers LDL-C & Reduce the Risk of Another MI or Stroke
- Watch A Video
See What Your Peers Are Saying
About This Treatment Option.
- HCP Treatment Information
Learn About a Treatment Option for
Patients with CV Disease.
- Real Patient Stories
Watch Patients Talk About Their
LDL-C & Experience with ASCVD.
- Resources for Patients
Get Helpful and Downloadable
Resources to Support Your Practice.
- Connect With A Rep
Connect With A Representative For
Resources or Support.
- Review Patient Profiles
Identify Patients Who Are At
Risk of Another CV Event.
- Watch A Video
Search results
- Treatment is with antiplatelets, anticoagulants, nitrates, beta-blockers, statins, and reperfusion therapy. For ST-segment-elevation myocardial infarction, emergency reperfusion is via fibrinolytic drugs, percutaneous intervention, or, occasionally, coronary artery bypass graft surgery.
www.merckmanuals.com › professional › cardiovascular-disordersAcute Myocardial Infarction (MI) - Cardiovascular Disorders ...
People also ask
How is ST elevation myocardial infarction treated?
What is non-ST-segment elevation myocardial infarction (NSTEMI)?
Do guidelines improve the standard of care for ST-elevation myocardial infarction?
This review article summarizes the latest evidence concerning clinical diagnosis and treatment of acute myocardial infarction. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond - Journal of Cardiology
Treatment is with antiplatelets, anticoagulants, nitrates, beta-blockers, statins, and reperfusion therapy. For ST-segment-elevation myocardial infarction, emergency reperfusion is via fibrinolytic drugs, percutaneous intervention, or, occasionally, coronary artery bypass graft surgery.
Dec 17, 2012 · Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
- Patrick T. O'Gara, Frederick G. Kushner, Deborah D. Ascheim, Donald E. Casey, Mina K Chung, James A....
- 2013
Apr 26, 2024 · Patients with severe and acute myocardial infarction (ie, ST-elevation myocardial infarction [STEMI]) require rapid diagnosis and treatment to reduce the risk of death and permanent myocardial injury [ 1 ]. This topic provides an overview of STEMI management from presentation to the period immediately after revascularization.
ST-segment elevation (equal to or greater than 1 mV) in contiguous leads provides strong evidence of thrombotic coronary arterial occlusion and makes the patient a candidate for immediate reperfusion therapy, either by fibrinolysis or primary percutaneous transluminal coronary angioplasty (PTCA).
- Thomas J. Ryan, Jeffrey L. Anderson, Elliott M. Antman, Blaine A. Braniff, Neil H. Brooks, Robert M....
- 1996
Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI ...
Society guideline links: ST-elevation myocardial infarction (STEMI) Supraventricular arrhythmias after myocardial infarction; Treatment of acute decompensated heart failure in acute coronary syndromes; Troponin testing: Clinical use; Ventricular arrhythmias during acute myocardial infarction: Incidence, mechanisms, and clinical features
Ad
related to: what is navd elevation myocardial infarction treatmentLower LDL-C and Reduce the Risk of Another MI. Get Info on a Treatment Option That Lowers LDL-C & Reduce the Risk of Another MI or Stroke